---
figid: PMC7054240__fphar-11-00121-g007
figlink: pmc/articles/PMC7054240/figure/f7/
number: F7
caption: Scheme of the proposed mechanism by which SFI increases eNOS activity. Administration
  of SFI results in an increase in the gene and protein expression of eNOS and promotes
  the eNOS phosphorylation at Ser1177 but inhibits the eNOS phosphorylation at Thr
  495 and decreases the Cav-1 content, ultimately resulting in enhanced NO production.
  This effect was antagonized by the PI3K/Akt signaling pathway inhibitor LY294002.
  The inhibitor used and its location of action is also indicated.
pmcid: PMC7054240
papertitle: Shenfu Injection Promotes Vasodilation by Enhancing eNOS Activity Through
  the PI3K/Akt Signaling Pathway In Vitro .
reftext: Jinqiang Zhu, et al. Front Pharmacol. 2020;11:121.
pmc_ranked_result_index: '26777'
pathway_score: 0.9498652
filename: fphar-11-00121-g007.jpg
figtitle: Scheme of the proposed mechanism by which SFI increases eNOS activity
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7054240__fphar-11-00121-g007.html
  '@type': Dataset
  description: Scheme of the proposed mechanism by which SFI increases eNOS activity.
    Administration of SFI results in an increase in the gene and protein expression
    of eNOS and promotes the eNOS phosphorylation at Ser1177 but inhibits the eNOS
    phosphorylation at Thr 495 and decreases the Cav-1 content, ultimately resulting
    in enhanced NO production. This effect was antagonized by the PI3K/Akt signaling
    pathway inhibitor LY294002. The inhibitor used and its location of action is also
    indicated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CAV1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - ENO2
  - ENO3
  - ENO1
  - ENO4
  - AKT2
  - AKT3
  - AKT1
  - L-Arginine
  - Ser11771
  - LY294002
  - ENO
  - O
genes:
- word: CaV-1
  symbol: CAV1
  source: hgnc_symbol
  hgnc_symbol: CAV1
  entrez: '857'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO2
  entrez: '2026'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO3
  entrez: '2027'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO1
  entrez: '2023'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO4
  entrez: '387712'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: L-Arginine
  source: ''
  identifier: ''
- word: Ser11771
  source: MESH
  identifier: C530429
- word: LY294002
  source: MESH
  identifier: C085911
- word: ENO
  source: MESH
  identifier: C095157
- word: O
  source: MESH
  identifier: D013481
diseases: []
figid_alias: PMC7054240__F7
redirect_from: /figures/PMC7054240__F7
figtype: Figure
---
